Not that I’m telling United States Anti-Doping Agency (USADA) how to do its job, but what’s the point of testing mixed martial arts (MMA) fighters who are already suspended from active competition?
Ultimate Fighting Championship (UFC) was recently notified of a potential anti-doping policy violation stemming from an out-of-competition sample taken from middleweight veteran Ricardo Abreu, 32, back on Dec. 21, 2016.
The 5-1 Brazilian, who hasn’t seen action in nearly two years, is already under suspension for the anabolic steroid metabolites 19-norandrosterone (19-NA) and 19-noretiocholanolone, detected in a sample collected last June.
More on that misstep here.
Abreu is currently sidelined until July 1, 2018; however, this latest setback could lengthen that disciplinary timeout. Naturally, the organization promises a “fair legal review process that is afforded to all athletes before any sanctions are imposed.”
Said process may take several weeks.
Either way, USADA will have to keep the results coming in order to justify this.
Source:: mma mania